Consolidated Statement Of Profit Or Loss

Solasia Pharma K.K. - Filing #7337315

Concept 2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
11,000,000 JPY
220,000,000 JPY
Cost of sales
11,000,000 JPY
91,000,000 JPY
Gross profit
0 JPY
128,000,000 JPY
Selling, general and administrative expenses
232,000,000 JPY
280,000,000 JPY
Operating profit (loss)
-307,000,000 JPY
-245,000,000 JPY
Finance income
0 JPY
0 JPY
Finance costs
10,000,000 JPY
0 JPY
Share of profit (loss) of investments accounted for using equity method
0 JPY
-1,000,000 JPY
Profit (loss) before tax
-318,000,000 JPY
-247,000,000 JPY
Income tax expense
-8,000,000 JPY
-6,000,000 JPY
Profit (loss)
JPY
-310,000,000 JPY
JPY
-310,000,000 JPY
JPY
JPY
JPY
JPY
JPY
-241,000,000 JPY
JPY
-241,000,000 JPY
JPY
JPY
JPY
JPY
Profit (loss) attributable to
Owners of parent
-310,000,000 JPY
-241,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
-1.78
-1.44
Diluted earnings (loss) per share
-1.78
-1.44

Talk to a Data Expert

Have a question? We'll get back to you promptly.